PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS
PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS NEW YORK, Jan. 23 /PRNewswire/ -- Edmund T. Pratt, Jr., chairman of
Pfizer Inc since 1972, will retire March 1 and become chairman emeritus. As announced last year, he will be succeeded as chairman by William C. Steere, Jr., president and chief executive officer. Pratt will continue to serve on the board of directors.
"Pfizer is a great company" said Pratt. "I consider myself very privileged to have been in a leadership role for so long and I look forward to providing whatever help I can to the new team." The board also announced that effective the same date Edward C. Bessey and Jean-Paul Valles, Ph.D., have been elected vice chairmen and that Barry M. Bloom, Ph.D., Henry A. McKinnell, Ph.D., and Robert Neimeth will become executive vice presidents. "We look forward to continuing the momentum provided by Ed Pratt during his long and distinguished career as Pfizer's CEO and chairman", said Steere. The board of directors added, "Ed Pratt has done an outstanding job during his 20 years of heading Pfizer. Not only has the company had a tremendous growth in sales and earnings under his leadership, but the billions Ed Pratt has invested in research has assured Pfizer shareholders of what appears to be an equally promising future. He also has to be commended for the systematic and orderly manner in which he positioned the new executive team for the exciting challenges that lie ahead." Pratt was named president of Pfizer Inc in 1971 and elected chairman of the board and chief executive officer in 1972. Steere became president and chief executive officer of Pfizer Inc in 1991. Their biographies and those of Bessey, Valles, Bloom, McKinnell and Neimeth follow. Pfizer Inc is a diversified, research-based health care company with businesses in pharmaceuticals, hospital products, consumer products, animal health, and specialty chemicals and minerals. -0- 1/23/92 /CONTACT: A.A. Biesada, 212-573-2055, or Rick Honey, 212-573-2051, both of Pfizer/ /FIRST AND FINAL ADD - BIOGRAPHICAL INFORMATION TO FOLLOW/ (PFE) CO: Pfizer Inc ST: New York IN: MTC SU: PER SM -- NY066 -- 2841 01/23/92 13:17 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 23, 1992|
|Previous Article:||PFIZER RAISES FIRST QUARTER 1992 DIVIDEND TO 37 CENTS|
|Next Article:||ARCO CHEMICAL REPORTS YEAR-END RESULTS|